Allspring Global Investments
PRTK

Allspring Global Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Allspring Global Investments’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-90,234
Closed -$267K – 3019
2022
Q1 		$267K Sell
90,234
-146,897
-62% -$553K ﹤0.01% 2475
2021
Q4 		$1.06M Buy
+237,131
New +$1.12M ﹤0.01% 1906

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Allspring Global Investments's PRTK Position: Q2 2022 in Review

Allspring Global Investments sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 90,234 shares — an estimated $267K sold.

Allspring Global Investments first reported a position in PRTK in Q4 2021 and held it in 2 quarters. The position peaked at $1.06M in Q4 2021. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Allspring Global Investments reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 90,234 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $267K.
  • Allspring Global Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Paratek Pharmaceuticals, Inc. position peaked at $1.06M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.